[{
  "_id": {
    "$oid": "671a2b185ffdb81650f82994"
  },
  "nct_id": "NCT00000106",
  "conditions": [
    "Rheumatism"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "65 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Entire body as a whole",
      "Enzyme Unit",
      "Fever"
    ],
    "outcomes": []
  },
  "title": "41.8 Degree Centigrade Whole Body Hyperthermia for the Treatment of Rheumatoid Diseases"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f82995"
  },
  "nct_id": "NCT00000102",
  "conditions": [
    "Congenital adrenal hyperplasia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "14 Years",
      "maximum_age": "35 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "nifedipine"
    ],
    "outcomes": []
  },
  "title": "Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f82996"
  },
  "nct_id": "NCT00000107",
  "conditions": [
    "Congenital Heart Defects",
    "Congenital MeSH qualifier"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "17 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "Body Water Content in Cyanotic Congenital Heart Disease"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f82997"
  },
  "nct_id": "NCT00000105",
  "conditions": [
    "Cancer Genus"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Tetanus Vaccine",
      "Vaccines"
    ],
    "outcomes": []
  },
  "title": "Vaccination With Tetanus and KLH to Assess Immune Responses."
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f82998"
  },
  "nct_id": "NCT00000104",
  "conditions": [
    "Lead Poisoning"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "0 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "FEMALE"
    },
    "interventions": [
      "Attention",
      "Early repolarization",
      "Measurement",
      "Memory"
    ],
    "outcomes": []
  },
  "title": "Does Lead Burden Alter Neuropsychological Development?"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f82999"
  },
  "nct_id": "NCT00000110",
  "conditions": [
    "BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "49 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Dietary Fats",
      "Magnetic Resonance Spectroscopy"
    ],
    "outcomes": []
  },
  "title": "Influence of Diet and Endurance Running on Intramuscular Lipids Measured at 4.1 TESLA"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f8299a"
  },
  "nct_id": "NCT00000108",
  "conditions": [
    "Cardiovascular Diseases",
    "Coronary Artery Disease"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "50 Years",
      "maximum_age": "65 Years",
      "country": "United States",
      "gender": "FEMALE"
    },
    "interventions": [
      "Exercise"
    ],
    "outcomes": []
  },
  "title": "Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f8299b"
  },
  "nct_id": "NCT00000111",
  "conditions": [
    "Mouth Diseases"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Graft material",
      "Mucosal graft",
      "Oral",
      "Oral mucous membrane structure"
    ],
    "outcomes": []
  },
  "title": "Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f8299c"
  },
  "nct_id": "NCT00000112",
  "conditions": [
    "Acanthosis Nigricans",
    "BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20",
    "Diabetes",
    "Glucose Intolerance (disease)"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "8 Years",
      "maximum_age": "18 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "Prevalence of Carbohydrate Intolerance in Lean and Obese Children"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f8299d"
  },
  "nct_id": "NCT00000113",
  "conditions": [
    "Myopia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "6 Years",
      "maximum_age": "12 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Progressive addition glasses",
      "Single vision glasses"
    ],
    "outcomes": []
  },
  "title": "Correction of Myopia Evaluation Trial (COMET)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f8299e"
  },
  "nct_id": "NCT00000115",
  "conditions": [
    "Macular retinal edema"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "8 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "acetazolamide"
    ],
    "outcomes": []
  },
  "title": "Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f8299f"
  },
  "nct_id": "NCT00000117",
  "conditions": [
    "Optic Neuritis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Immunoglobulins"
    ],
    "outcomes": []
  },
  "title": "Intravenous Immunoglobulin Therapy in Optic Neuritis"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a0"
  },
  "nct_id": "NCT00000114",
  "conditions": [
    "Retinitis Pigmentosa"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "49 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Vitamin A Drug Class",
      "Vitamin E Drug Class"
    ],
    "outcomes": []
  },
  "title": "Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a1"
  },
  "nct_id": "NCT00000118",
  "conditions": [
    "Acquired Immunodeficiency Syndrome",
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Delivery system",
      "Drug Delivery Systems",
      "Intraocular",
      "Sustained Release Dosage Form",
      "Sustained-Release Preparations"
    ],
    "outcomes": []
  },
  "title": "Ganciclovir Implant Study for Cytomegalovirus Retinitis"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a2"
  },
  "nct_id": "NCT00000119",
  "conditions": [
    "Cataract",
    "Uveitis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Artificial lens, device",
      "Changing",
      "Surface",
      "heparin"
    ],
    "outcomes": []
  },
  "title": "Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a3"
  },
  "nct_id": "NCT00000120",
  "conditions": [
    "Chlamydia Infections",
    "Gonococcal Ophthalmia Neonatorum"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "1 Year",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Argentum nitricum, silver nitrate",
      "Drop Dosing Unit",
      "Erythromycin Topical Ointment"
    ],
    "outcomes": []
  },
  "title": "Clinical Trial of Eye Prophylaxis in the Newborn"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a4"
  },
  "nct_id": "NCT00000121",
  "conditions": [
    "Esotropia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "3 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Eyeglasses",
      "Prism correction"
    ],
    "outcomes": []
  },
  "title": "The Prism Adaptation Study (PAS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a5"
  },
  "nct_id": "NCT00000122",
  "conditions": [
    "Glaucoma"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "fluorouracil"
    ],
    "outcomes": []
  },
  "title": "Fluorouracil Filtering Surgery Study (FFSS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a6"
  },
  "nct_id": "NCT00000116",
  "conditions": [
    "Retinitis Pigmentosa"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "55 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Control function",
      "Docosahexaenoic Acids",
      "Fatty Acids",
      "Vitamin A Drug Class"
    ],
    "outcomes": []
  },
  "title": "Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a7"
  },
  "nct_id": "NCT00000123",
  "conditions": [
    "Astigmatism",
    "Myopia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "20 Years",
      "maximum_age": "35 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Contact Lenses",
      "Polymethyl Methacrylate",
      "silicones"
    ],
    "outcomes": []
  },
  "title": "The Berkeley Orthokeratology Study"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a8"
  },
  "nct_id": "NCT00000126",
  "conditions": [
    "Optic Neuropathy, Ischemic"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "50 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "General surgery specialty"
    ],
    "outcomes": []
  },
  "title": "Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829a9"
  },
  "nct_id": "NCT00000124",
  "conditions": [
    "Choroid Neoplasms",
    "Uveitis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Brachytherapy",
      "Eye Enucleation procedure"
    ],
    "outcomes": []
  },
  "title": "Collaborative Ocular Melanoma Study (COMS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829aa"
  },
  "nct_id": "NCT00000125",
  "conditions": [
    "Glaucoma",
    "Ocular Hypertension"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "40 Years",
      "maximum_age": "80 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Eye Drops",
      "Topical surface",
      "ocular hypotensive"
    ],
    "outcomes": [
      "Glaucoma, Primary Open Angle",
      "Hypotensive",
      "Incidence",
      "Patients"
    ]
  },
  "title": "Ocular Hypertension Treatment Study (OHTS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ab"
  },
  "nct_id": "NCT00000127",
  "conditions": [
    "Optic Neuropathy, Ischemic"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "50 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Decompression, Surgical",
      "Optic nerve sheath"
    ],
    "outcomes": []
  },
  "title": "Ischemic Optic Neuropathy Decompression Trial (IONDT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ac"
  },
  "nct_id": "NCT00000128",
  "conditions": [
    "Esophoria",
    "Myopia",
    "Strabismus"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "6 Years",
      "maximum_age": "12 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Bifocal",
      "Bifocal glasses (physical object)",
      "Eyeglasses",
      "Spectacle lens"
    ],
    "outcomes": []
  },
  "title": "A Trial of Bifocals in Myopic Children With Esophoria"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ad"
  },
  "nct_id": "NCT00000129",
  "conditions": [
    "Myopia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Keratotomy, Radial"
    ],
    "outcomes": []
  },
  "title": "Prospective Evaluation of Radial Keratotomy (PERK) Study"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ae"
  },
  "nct_id": "NCT00000131",
  "conditions": [
    "Retinal Diseases",
    "Retinal Vein Occlusion"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Light Coagulation"
    ],
    "outcomes": []
  },
  "title": "Central Vein Occlusion Study (CVOS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829af"
  },
  "nct_id": "NCT00000132",
  "conditions": [
    "Glaucoma, Open-Angle"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "50 Years",
      "maximum_age": "80 Years",
      "country": "Sweden",
      "gender": "ALL"
    },
    "interventions": [
      "Argon laser trabeculoplasty",
      "betaxolol"
    ],
    "outcomes": []
  },
  "title": "Early Manifest Glaucoma Trial (EMGT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b0"
  },
  "nct_id": "NCT00000130",
  "conditions": [
    "Endophthalmitis",
    "Eye Infection"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Antibiotic throat preparations",
      "Firstly",
      "Mechanical vitrectomy by pars plana approach"
    ],
    "outcomes": []
  },
  "title": "Endophthalmitis Vitrectomy Study (EVS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b1"
  },
  "nct_id": "NCT00000133",
  "conditions": [
    "Retinopathy of Prematurity"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "1 Year",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Cryotherapy",
      "Transcleral approach"
    ],
    "outcomes": []
  },
  "title": "Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b2"
  },
  "nct_id": "NCT00000135",
  "conditions": [
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Placebo Control",
      "sevirumab"
    ],
    "outcomes": [
      "Death Rate"
    ]
  },
  "title": "Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b3"
  },
  "nct_id": "NCT00000134",
  "conditions": [
    "Acquired Immunodeficiency Syndrome",
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "foscarnet",
      "ganciclovir"
    ],
    "outcomes": [
      "Morbidity - disease rate"
    ]
  },
  "title": "Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b4"
  },
  "nct_id": "NCT00000136",
  "conditions": [
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "foscarnet",
      "ganciclovir"
    ],
    "outcomes": [
      "Aspects of mortality statistics"
    ]
  },
  "title": "Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b5"
  },
  "nct_id": "NCT00000137",
  "conditions": [
    "Graft Rejection",
    "Keratoplasty"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "10 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Histocompatibility",
      "MATCHING"
    ],
    "outcomes": []
  },
  "title": "Collaborative Corneal Transplantation Studies (CCTS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b6"
  },
  "nct_id": "NCT00000138",
  "conditions": [
    "Herpes",
    "Keratitis",
    "Keratitis, Herpetic"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "acyclovir",
      "prednisolone phosphate"
    ],
    "outcomes": []
  },
  "title": "Herpetic Eye Disease Study (HEDS) I"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b7"
  },
  "nct_id": "NCT00000139",
  "conditions": [
    "Herpes",
    "Herpes Simplex Infections",
    "Keratitis",
    "Keratitis, Herpetic"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Stress",
      "acyclovir"
    ],
    "outcomes": []
  },
  "title": "Herpetic Eye Disease Study (HEDS) II"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b8"
  },
  "nct_id": "NCT00000140",
  "conditions": [
    "Proliferative vitreo-retinopathy",
    "Retinal Detachment"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Silicone Oils",
      "perflutren",
      "sulfur hexafluoride"
    ],
    "outcomes": []
  },
  "title": "The Silicone Study"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829b9"
  },
  "nct_id": "NCT00000142",
  "conditions": [
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "cidofovir"
    ],
    "outcomes": [
      "Continuance of life"
    ]
  },
  "title": "Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ba"
  },
  "nct_id": "NCT00000143",
  "conditions": [
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Administration via Implantation",
      "Intravenous",
      "Oral",
      "cidofovir",
      "ganciclovir"
    ],
    "outcomes": [
      "Continuance of life"
    ]
  },
  "title": "Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829bb"
  },
  "nct_id": "NCT00000144",
  "conditions": [
    "Glaucoma, Open-Angle"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "35 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Administration procedure",
      "Argon <invertebrate>",
      "Argon Ion Lasers",
      "Consent Type - Laser treatment"
    ],
    "outcomes": []
  },
  "title": "Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829bc"
  },
  "nct_id": "NCT00000146",
  "conditions": [
    "MS gene",
    "Optic Neuritis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "46 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "methylprednisolone",
      "prednisone"
    ],
    "outcomes": []
  },
  "title": "Optic Neuritis Treatment Trial (ONTT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829bd"
  },
  "nct_id": "NCT00000145",
  "conditions": [
    "Age related macular degeneration",
    "Cataract",
    "Lens Opacities"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "55 Years",
      "maximum_age": "80 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Antioxidants",
      "Dietary Zinc"
    ],
    "outcomes": []
  },
  "title": "Age-Related Eye Disease Study (AREDS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829be"
  },
  "nct_id": "NCT00000147",
  "conditions": [
    "MS gene",
    "Optic Neuritis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "46 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "methylprednisolone",
      "prednisone"
    ],
    "outcomes": []
  },
  "title": "Longitudinal Optic Neuritis Study (LONS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829bf"
  },
  "nct_id": "NCT00000148",
  "conditions": [
    "Glaucoma"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "35 Years",
      "maximum_age": "80 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Argon laser trabeculoplasty",
      "Trabeculectomy"
    ],
    "outcomes": []
  },
  "title": "Advanced Glaucoma Intervention Study (AGIS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c0"
  },
  "nct_id": "NCT00000149",
  "conditions": [
    "Glaucoma, Open-Angle"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "25 Years",
      "maximum_age": "75 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Adrenergic beta-Antagonists",
      "Argon laser trabeculoplasty",
      "Trabeculectomy"
    ],
    "outcomes": []
  },
  "title": "Collaborative Initial Glaucoma Treatment Study (CIGTS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c1"
  },
  "nct_id": "NCT00000151",
  "conditions": [
    "Blindness",
    "Diabetic Retinopathy"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "70 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Argon laser photocoagulation",
      "aspirin"
    ],
    "outcomes": []
  },
  "title": "Early Treatment Diabetic Retinopathy Study (ETDRS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c2"
  },
  "nct_id": "NCT00000150",
  "conditions": [
    "Age related macular degeneration",
    "Histoplasmosis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Excision",
      "Subfoveal choroidal neovascularization"
    ],
    "outcomes": []
  },
  "title": "Submacular Surgery Trials (SST)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c3"
  },
  "nct_id": "NCT00000152",
  "conditions": [
    "Age related macular degeneration"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "40 Years",
      "maximum_age": "84 Years",
      "country": "",
      "gender": "MALE"
    },
    "interventions": [
      "Beta carotene measurement",
      "aspirin"
    ],
    "outcomes": []
  },
  "title": "Randomized Trial of Beta-Carotene and Macular Degeneration"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c4"
  },
  "nct_id": "NCT00000156",
  "conditions": [
    "Retinopathy of Prematurity"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "1 Day",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Ambient",
      "Borg Scale Rating of Perceived Exertion Score 11",
      "Goggles",
      "Reduced"
    ],
    "outcomes": []
  },
  "title": "The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c5"
  },
  "nct_id": "NCT00000154",
  "conditions": [
    "Diabetic Retinopathy",
    "Retinal Detachment",
    "Vitreous Hemorrhage"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "70 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Vitrectomy"
    ],
    "outcomes": []
  },
  "title": "Diabetic Retinopathy Vitrectomy Study (DRVS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c6"
  },
  "nct_id": "NCT00000155",
  "conditions": [
    "Keratoconus"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c7"
  },
  "nct_id": "NCT00000157",
  "conditions": [
    "Cataract"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "40 Years",
      "maximum_age": "84 Years",
      "country": "",
      "gender": "MALE"
    },
    "interventions": [
      "aspirin"
    ],
    "outcomes": []
  },
  "title": "Randomized Trial of Aspirin and Cataracts in U.S. Physicians"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c8"
  },
  "nct_id": "NCT00000153",
  "conditions": [
    "Diabetes Mellitus",
    "Diabetic Retinopathy",
    "Retinal Neovascularization"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "79 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Administration procedure",
      "Argon <invertebrate>",
      "Argon Ion Lasers",
      "Blue green color",
      "Consent Type - Laser treatment",
      "Krypton",
      "Krypton laser device",
      "Laser light, red",
      "Radiological Exposure Device"
    ],
    "outcomes": []
  },
  "title": "Krypton-Argon Regression of Neovascularization Study (KARNS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829c9"
  },
  "nct_id": "NCT00000158",
  "conditions": [
    "Age related macular degeneration",
    "Choroidal Neovascularization",
    "Histoplasmosis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Argon laser photocoagulation",
      "Blue green color"
    ],
    "outcomes": []
  },
  "title": "Macular Photocoagulation Study (MPS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ca"
  },
  "nct_id": "NCT00000159",
  "conditions": [
    "Diabetes Mellitus",
    "Diabetic Retinopathy"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "56 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "sorbinil"
    ],
    "outcomes": []
  },
  "title": "Sorbinil Retinopathy Trial (SRT)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829cb"
  },
  "nct_id": "NCT00000160",
  "conditions": [
    "Blindness",
    "Diabetic Retinopathy"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "70 Years",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Argon <invertebrate>",
      "Infrared Photocoagulation Therapy",
      "xenon"
    ],
    "outcomes": []
  },
  "title": "Diabetic Retinopathy Study (DRS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829cc"
  },
  "nct_id": "NCT00000162",
  "conditions": [
    "Age related macular degeneration",
    "Pathologic",
    "Pathologic Neovascularization",
    "Vitreous Hemorrhage"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Argon laser photocoagulation",
      "Peripheral",
      "Scattered",
      "macular"
    ],
    "outcomes": []
  },
  "title": "Branch Vein Occlusion Study"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829cd"
  },
  "nct_id": "NCT00000161",
  "conditions": [
    "Age related macular degeneration",
    "Cataract"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "45 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "FEMALE"
    },
    "interventions": [
      "Beta carotene measurement",
      "Vitamin C Drug Class",
      "Vitamin E Drug Class",
      "aspirin"
    ],
    "outcomes": []
  },
  "title": "Randomized Trials of Vitamin Supplements and Eye Disease"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ce"
  },
  "nct_id": "NCT00000163",
  "conditions": [
    "Esotropia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "4 Weeks",
      "maximum_age": "20 Weeks",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "Congenital Esotropia Observational Study (CEOS)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829cf"
  },
  "nct_id": "NCT00000168",
  "conditions": [
    "Acquired Immunodeficiency Syndrome",
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "Longitudinal Study of Ocular Complications of AIDS (LSOCA)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d0"
  },
  "nct_id": "NCT00000169",
  "conditions": [
    "Myopia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "6 Years",
      "maximum_age": "14 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d1"
  },
  "nct_id": "NCT00000167",
  "conditions": [
    "Age related macular degeneration"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "50 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Administration procedure",
      "Low-intensity laser"
    ],
    "outcomes": []
  },
  "title": "Complications of Age-Related Macular Degeneration Prevention Trial"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d2"
  },
  "nct_id": "NCT00000170",
  "conditions": [
    "Amblyopia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "6 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Atropinum, atropine",
      "Eye patch"
    ],
    "outcomes": []
  },
  "title": "Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d3"
  },
  "nct_id": "NCT00000171",
  "conditions": [
    "Alzheimer's Disease",
    "Dyssomnias"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "55 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Recombinant melatonin"
    ],
    "outcomes": []
  },
  "title": "Study of Melatonin: Sleep Problems in Alzheimer's Disease"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d4"
  },
  "nct_id": "NCT00000172",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "0 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "galantamine"
    ],
    "outcomes": []
  },
  "title": "Evaluation of Galantamine in the Treatment of Alzheimer's Disease"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d5"
  },
  "nct_id": "NCT00000173",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "55 Years",
      "maximum_age": "90 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Vitamin E Drug Class",
      "donepezil"
    ],
    "outcomes": []
  },
  "title": "Memory Impairment Study (Mild Cognitive Impairment Study)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d6"
  },
  "nct_id": "NCT00000174",
  "conditions": [
    "Alzheimer's Disease",
    "Cognition Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "55 Years",
      "maximum_age": "85 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "rivastigmine"
    ],
    "outcomes": []
  },
  "title": "Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d7"
  },
  "nct_id": "NCT00000175",
  "conditions": [
    "Cognition Disorders",
    "Mood Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "65 Years",
      "maximum_age": "90 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Estrogen (disposition)",
      "Therapeutic Testosterone"
    ],
    "outcomes": []
  },
  "title": "The Effects of Sex Hormones on Cognition and Mood in Older Adults"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d8"
  },
  "nct_id": "NCT00000177",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "60 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "FEMALE"
    },
    "interventions": [
      "Estrogen (disposition)"
    ],
    "outcomes": []
  },
  "title": "Estrogen Hormone Protocol"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829d9"
  },
  "nct_id": "NCT00000176",
  "conditions": [
    "Alzheimer's Disease",
    "Memory Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "65 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "FEMALE"
    },
    "interventions": [
      "Estrogen (disposition)",
      "Progesterone [EPC]"
    ],
    "outcomes": []
  },
  "title": "Alzheimer's Disease Prevention Trial"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829da"
  },
  "nct_id": "NCT00000178",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "0 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "prednisone"
    ],
    "outcomes": []
  },
  "title": "Multicenter Trial of Prednisone in Alzheimer's Disease"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829db"
  },
  "nct_id": "NCT00000179",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "50 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "haloperidol",
      "trazodone"
    ],
    "outcomes": []
  },
  "title": "Agitation in Alzheimer's Disease"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829dc"
  },
  "nct_id": "NCT00000187",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "28 Years",
      "maximum_age": "47 Years",
      "country": "United States",
      "gender": "MALE"
    },
    "interventions": [
      "Ritanserin"
    ],
    "outcomes": []
  },
  "title": "Ritanserin in Treatment of Cocaine Dependence - 1"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829dd"
  },
  "nct_id": "NCT00000180",
  "conditions": [
    "Memory Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "AIT 082"
    ],
    "outcomes": []
  },
  "title": "AIT-082 Phase 1B Study"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829de"
  },
  "nct_id": "NCT00000188",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "selegiline"
    ],
    "outcomes": []
  },
  "title": "Selegiline in Treatment of Cocaine Dependence - 2"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829df"
  },
  "nct_id": "NCT00000189",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "MALE"
    },
    "interventions": [
      "gepirone"
    ],
    "outcomes": []
  },
  "title": "Gepirone vs Placebo in Treatment of Cocaine Dependence - 3"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e0"
  },
  "nct_id": "NCT00000190",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "MALE"
    },
    "interventions": [
      "Parotid Gland"
    ],
    "outcomes": []
  },
  "title": "Cocaine in Parotid Saliva, Blood and Urine - 4"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e1"
  },
  "nct_id": "NCT00000192",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Lamotrigine measurement"
    ],
    "outcomes": []
  },
  "title": "Neurobiology of Opioid Dependence: 1 - 1"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e2"
  },
  "nct_id": "NCT00000191",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "51 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Carbamazepine measurement"
    ],
    "outcomes": []
  },
  "title": "Carbamazepine Treatment for Cocaine Dependence - 5"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e3"
  },
  "nct_id": "NCT00000195",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "naltrexone"
    ],
    "outcomes": []
  },
  "title": "Neurobiology of Opioid Dependence: 4 - 4"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e4"
  },
  "nct_id": "NCT00000193",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "MALE"
    },
    "interventions": [
      "Gamma - unit of measure"
    ],
    "outcomes": []
  },
  "title": "Neurobiology of Opioid Dependence: 2 - 2"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e5"
  },
  "nct_id": "NCT00000194",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "MALE"
    },
    "interventions": [
      "cycloserine"
    ],
    "outcomes": []
  },
  "title": "Neurobiology of Opioid Dependence: 3 - 3"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e6"
  },
  "nct_id": "NCT00000196",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "naltrexone"
    ],
    "outcomes": []
  },
  "title": "Neurobiology of Opioid Dependence: 5 - 5"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e7"
  },
  "nct_id": "NCT00000198",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "45 Years",
      "country": "United States",
      "gender": "MALE"
    },
    "interventions": [
      "piracetam"
    ],
    "outcomes": []
  },
  "title": "Piracetam for Treatment of Cocaine Addiction - 3"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e8"
  },
  "nct_id": "NCT00000199",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "piracetam"
    ],
    "outcomes": []
  },
  "title": "Piracetam for Treatment of Cocaine Addiction, Phase II - 4"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829e9"
  },
  "nct_id": "NCT00000197",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "25 Years",
      "maximum_age": "49 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "propranolol"
    ],
    "outcomes": []
  },
  "title": "Propranolol for Treatment of Cocaine Addiction - 2"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ea"
  },
  "nct_id": "NCT00000200",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "45 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "methadone"
    ],
    "outcomes": []
  },
  "title": "Cocaine Effects in Humans: Physiology and Behavior - 1"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829eb"
  },
  "nct_id": "NCT00000201",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "FEMALE"
    },
    "interventions": [
      "selegiline"
    ],
    "outcomes": []
  },
  "title": "Pharmacological Modulation of Cocaine Effects - 1"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ec"
  },
  "nct_id": "NCT00000202",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "65 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Buprenorphine Maintenance for Opioid Addicts - 1"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ed"
  },
  "nct_id": "NCT00000205",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Buprenorphine Maintenance Protocol - 1"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ee"
  },
  "nct_id": "NCT00000203",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Buprenorphine Maintenance for Opioid Addicts - 2"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829ef"
  },
  "nct_id": "NCT00000204",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Buprenorphine Maintenance for Opioid Addicts - 3"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829f0"
  },
  "nct_id": "NCT00000206",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Clinical Rescue Protocol - 2"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829f1"
  },
  "nct_id": "NCT00000208",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Methadone/Buprenorphine Cross-Over Study - 4"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829f2"
  },
  "nct_id": "NCT00000207",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Multicenter Clinical Trial of Buprenorphine - 3"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829f3"
  },
  "nct_id": "NCT00000210",
  "conditions": [
    "Cocaine-Related Disorders",
    "Heroin Dependence"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "26 Years",
      "maximum_age": "41 Years",
      "country": "United States",
      "gender": "MALE"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Treatment Efficacy for Drug Abuse and AIDS Prevention - 1"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829f4"
  },
  "nct_id": "NCT00000211",
  "conditions": [
    "Cocaine-Related Disorders",
    "Heroin Dependence"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "26 Years",
      "maximum_age": "41 Years",
      "country": "United States",
      "gender": "MALE"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Treatment Efficacy for Drug Abuse and AIDS Prevention - 2"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829f5"
  },
  "nct_id": "NCT00000212",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "45 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "desipramine"
    ],
    "outcomes": []
  },
  "title": "IV Cocaine Abuse: A Laboratory Model - 1"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829f6"
  },
  "nct_id": "NCT00000213",
  "conditions": [
    "Cocaine-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "45 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Fluoxetine measurement"
    ],
    "outcomes": []
  },
  "title": "IV Cocaine Abuse: A Laboratory Model - 2"
},
{
  "_id": {
    "$oid": "671a2b185ffdb81650f829f7"
  },
  "nct_id": "NCT00000209",
  "conditions": [
    "Opioid-Related Disorders"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "21 Years",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Buprenorphine measurement (procedure)"
    ],
    "outcomes": []
  },
  "title": "Buprenorphine Dosing Interval - 5"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51a2"
  },
  "nct_id": "NCT00001030",
  "conditions": [
    "HIV Infections",
    "Mycobacterium avium-intracellulare Infection"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "clarithromycin",
      "rifabutin"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51a3"
  },
  "nct_id": "NCT00001027",
  "conditions": [
    "HIV Infections",
    "Pneumocystis Carinii reagents",
    "Pneumonia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "1 Month",
      "maximum_age": "6 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "pentamidine isethionate"
    ],
    "outcomes": []
  },
  "title": "A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51a4"
  },
  "nct_id": "NCT00001029",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "zalcitabine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51a5"
  },
  "nct_id": "NCT00001031",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "16 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "HIV",
      "HIV 1+2"
    ],
    "outcomes": []
  },
  "title": "A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51a6"
  },
  "nct_id": "NCT00001028",
  "conditions": [
    "HIV Infections",
    "Pneumocystis Carinii reagents",
    "Pneumonia"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "dapsone",
      "pentamidine isethionate"
    ],
    "outcomes": []
  },
  "title": "A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51a7"
  },
  "nct_id": "NCT00001032",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "3 Months",
      "maximum_age": "12 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "zalcitabine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51a8"
  },
  "nct_id": "NCT00001033",
  "conditions": [
    "HIV Infections",
    "Tuberculosis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ethambutol hydrochloride",
      "isoniazid",
      "levofloxacin",
      "pyrazinamide",
      "pyridoxine hydrochloride",
      "rifampin"
    ],
    "outcomes": []
  },
  "title": "The Treatment of Tuberculosis in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51a9"
  },
  "nct_id": "NCT00001034",
  "conditions": [
    "Cytomegalovirus Retinitis",
    "Gastrointestinal Diseases",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ganciclovir"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51aa"
  },
  "nct_id": "NCT00001035",
  "conditions": [
    "HIV Infections",
    "Hepatitis C"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "IFNA2 gene",
      "didanosine",
      "zalcitabine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ab"
  },
  "nct_id": "NCT00001037",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ENPEP gene",
      "Procedure Agents Domain",
      "Vaccines"
    ],
    "outcomes": []
  },
  "title": "A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ac"
  },
  "nct_id": "NCT00001039",
  "conditions": [
    "HIV Infections",
    "Mycobacterium avium-intracellulare Infection"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "clarithromycin",
      "ethambutol hydrochloride"
    ],
    "outcomes": []
  },
  "title": "Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ad"
  },
  "nct_id": "NCT00001040",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "saquinavir",
      "zalcitabine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ae"
  },
  "nct_id": "NCT00001041",
  "conditions": [
    "HIV Infections",
    "Pregnancy"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "16 Years",
      "maximum_age": "40 Years",
      "country": "United States",
      "gender": "FEMALE"
    },
    "interventions": [
      "HIV"
    ],
    "outcomes": []
  },
  "title": "Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51af"
  },
  "nct_id": "NCT00001043",
  "conditions": [
    "HIV Infections",
    "HIV Seronegativity"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ENPEP gene",
      "Procedure Agents Domain",
      "Vaccines"
    ],
    "outcomes": []
  },
  "title": "A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b0"
  },
  "nct_id": "NCT00001042",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Acetylmuramyl-Alanyl-Isoglutamine",
      "Encapsulated (qualifier value)",
      "Etoposide-Platinol Regimen",
      "HIV 1+2",
      "Lipid A",
      "Liposomes",
      "MF59 oil emulsion",
      "MTTP gene",
      "Syntex adjuvant formulation",
      "aluminum hydroxide"
    ],
    "outcomes": []
  },
  "title": "A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b1"
  },
  "nct_id": "NCT00001044",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "HIV",
      "QS-21",
      "aluminum hydroxide"
    ],
    "outcomes": []
  },
  "title": "A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults."
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b2"
  },
  "nct_id": "NCT00001036",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Glycolates",
      "IL2 gene",
      "Polyethylene",
      "thymalfasin",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b3"
  },
  "nct_id": "NCT00001046",
  "conditions": [
    "HIV Infections",
    "HIV Seronegativity",
    "Pregnancy"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "16 Years",
      "maximum_age": "40 Years",
      "country": "United States",
      "gender": "FEMALE"
    },
    "interventions": [
      "HIV 1+2",
      "MF59 oil emulsion"
    ],
    "outcomes": []
  },
  "title": "Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b4"
  },
  "nct_id": "NCT00001047",
  "conditions": [
    "HIV Infections",
    "Mycobacterium avium-intracellulare Infection"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "clarithromycin",
      "clofazimine",
      "ethambutol hydrochloride",
      "rifabutin"
    ],
    "outcomes": []
  },
  "title": "Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b5"
  },
  "nct_id": "NCT00001045",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "nevirapine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b6"
  },
  "nct_id": "NCT00001049",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "1 Day",
      "maximum_age": "3 Months",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b7"
  },
  "nct_id": "NCT00001048",
  "conditions": [
    "HIV Infections",
    "Leukoencephalopathy",
    "Multifocal",
    "Progressive"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "65 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "CSF3 gene",
      "cytarabine",
      "didanosine",
      "zalcitabine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b8"
  },
  "nct_id": "NCT00001050",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "Study of Women Who Have AIDS"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51b9"
  },
  "nct_id": "NCT00001052",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "HIV",
      "QS-21",
      "aluminum hydroxide"
    ],
    "outcomes": []
  },
  "title": "A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ba"
  },
  "nct_id": "NCT00001038",
  "conditions": [
    "Cytomegalovirus Infections",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "acyclovir",
      "valacyclovir hydrochloride"
    ],
    "outcomes": []
  },
  "title": "A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51bb"
  },
  "nct_id": "NCT00001053",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "FAM72A gene",
      "HIV Core Protein p24",
      "VHLL gene",
      "aluminum hydroxide"
    ],
    "outcomes": []
  },
  "title": "A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51bc"
  },
  "nct_id": "NCT00001054",
  "conditions": [
    "Chickenpox",
    "HIV Infections",
    "Herpes Simplex Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "4 Years",
      "maximum_age": "12 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "valacyclovir hydrochloride"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51bd"
  },
  "nct_id": "NCT00001055",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "AIDSVAX",
      "C4A gene",
      "Glycoproteins",
      "HIV 1+2",
      "Rabies (disorder)"
    ],
    "outcomes": []
  },
  "title": "A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51be"
  },
  "nct_id": "NCT00001057",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51bf"
  },
  "nct_id": "NCT00001058",
  "conditions": [
    "HIV Infections",
    "Mycobacterium avium-intracellulare Infection"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "clarithromycin",
      "ethambutol hydrochloride",
      "indinavir sulfate",
      "rifabutin",
      "ritonavir"
    ],
    "outcomes": []
  },
  "title": "A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c0"
  },
  "nct_id": "NCT00001059",
  "conditions": [
    "HIV Infections",
    "Malignant neoplasm of soft tissue"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "CSF3 gene",
      "Liposomes",
      "bleomycin sulfate",
      "doxorubicin hydrochloride",
      "vincristine sulfate"
    ],
    "outcomes": []
  },
  "title": "Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c1"
  },
  "nct_id": "NCT00001060",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Anterior bronchopulmonary segment of superior pulmonary vein",
      "C4A wt Allele",
      "HIV-1",
      "Peptides",
      "Polyvalent Vaccine"
    ],
    "outcomes": []
  },
  "title": "A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c2"
  },
  "nct_id": "NCT00001061",
  "conditions": [
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "foscarnet sodium",
      "ganciclovir",
      "sevirumab"
    ],
    "outcomes": []
  },
  "title": "Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c3"
  },
  "nct_id": "NCT00001062",
  "conditions": [
    "Cytomegalovirus Retinitis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ganciclovir"
    ],
    "outcomes": []
  },
  "title": "A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c4"
  },
  "nct_id": "NCT00001063",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "stavudine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c5"
  },
  "nct_id": "NCT00001064",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Allogeneic",
      "Dendritic Cells"
    ],
    "outcomes": []
  },
  "title": "A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c6"
  },
  "nct_id": "NCT00001067",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "lamivudine",
      "stavudine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c7"
  },
  "nct_id": "NCT00001065",
  "conditions": [
    "Candidiasis",
    "HIV Infections",
    "Oral"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "amphotericin B"
    ],
    "outcomes": []
  },
  "title": "A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c8"
  },
  "nct_id": "NCT00001066",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "3 Months",
      "maximum_age": "15 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "lamivudine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51c9"
  },
  "nct_id": "NCT00001068",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "lamivudine"
    ],
    "outcomes": []
  },
  "title": "A Study of Disease Progression and Anti-HIV Treatments"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ca"
  },
  "nct_id": "NCT00001069",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51cb"
  },
  "nct_id": "NCT00001070",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "",
      "gender": "ALL"
    },
    "interventions": [
      "Oral",
      "Vitamin C Drug Class"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51cc"
  },
  "nct_id": "NCT00001071",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "CSF3 gene"
    ],
    "outcomes": []
  },
  "title": "A Study of Stem Cells and Filgrastim"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51cd"
  },
  "nct_id": "NCT00001072",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "AIDSVAX",
      "C4A gene",
      "Glycoproteins",
      "HIV 1+2",
      "Rabies (disorder)"
    ],
    "outcomes": []
  },
  "title": "A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ce"
  },
  "nct_id": "NCT00001075",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "16 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "lamivudine",
      "ritonavir",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51cf"
  },
  "nct_id": "NCT00001073",
  "conditions": [
    "Cervix Uteri",
    "Dysplasia",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "FEMALE"
    },
    "interventions": [
      "isotretinoin"
    ],
    "outcomes": []
  },
  "title": "Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d0"
  },
  "nct_id": "NCT00001076",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "AIDSVAX",
      "C4A gene",
      "Glycoproteins",
      "HIV 1+2",
      "Rabies (disorder)"
    ],
    "outcomes": []
  },
  "title": "A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d1"
  },
  "nct_id": "NCT00001074",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "hydroxyurea"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d2"
  },
  "nct_id": "NCT00001078",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "2 Years",
      "maximum_age": "21 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "FDA Inactivation",
      "Hepatitis A Vaccines"
    ],
    "outcomes": []
  },
  "title": "A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d3"
  },
  "nct_id": "NCT00001079",
  "conditions": [
    "HIV Infections",
    "HIV Wasting Syndrome"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "megestrol acetate",
      "testosterone enanthate"
    ],
    "outcomes": []
  },
  "title": "A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d4"
  },
  "nct_id": "NCT00001077",
  "conditions": [
    "HIV Infections",
    "HIV Wasting Syndrome"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Dietary Supplements",
      "Minerals",
      "Multivitamin preparation",
      "Peptamen"
    ],
    "outcomes": []
  },
  "title": "A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d5"
  },
  "nct_id": "NCT00001081",
  "conditions": [
    "Cryptosporidiosis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "nitazoxanide"
    ],
    "outcomes": []
  },
  "title": "A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d6"
  },
  "nct_id": "NCT00001080",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "23",
      "Influenza virus vaccine",
      "Pneumococcal Vaccine:-:Point in time:^Patient:-",
      "Polyvalence",
      "lamivudine"
    ],
    "outcomes": []
  },
  "title": "Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d7"
  },
  "nct_id": "NCT00001083",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "2 Years",
      "maximum_age": "17 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "indinavir sulfate",
      "lamivudine",
      "nevirapine",
      "ritonavir",
      "stavudine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d8"
  },
  "nct_id": "NCT00001084",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "indinavir sulfate",
      "lamivudine",
      "stavudine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51d9"
  },
  "nct_id": "NCT00001082",
  "conditions": [
    "Cytomegalovirus Infections",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Placebo Control",
      "adefovir dipivoxil",
      "levocarnitine"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51da"
  },
  "nct_id": "NCT00001085",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "amprenavir",
      "lamivudine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51db"
  },
  "nct_id": "NCT00001086",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "16 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "abacavir sulfate",
      "efavirenz",
      "indinavir sulfate"
    ],
    "outcomes": []
  },
  "title": "A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51dc"
  },
  "nct_id": "NCT00001087",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "adefovir dipivoxil",
      "didanosine",
      "efavirenz",
      "lamivudine",
      "levocarnitine",
      "nelfinavir mesylate",
      "ritonavir",
      "saquinavir",
      "stavudine",
      "zalcitabine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51dd"
  },
  "nct_id": "NCT00001088",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "400",
      "bupivacaine hydrochloride"
    ],
    "outcomes": []
  },
  "title": "A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51de"
  },
  "nct_id": "NCT00001089",
  "conditions": [
    "Cytomegalovirus Infections",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51df"
  },
  "nct_id": "NCT00001056",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ENPEP gene",
      "Procedure Agents Domain",
      "Vaccines"
    ],
    "outcomes": []
  },
  "title": "A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e0"
  },
  "nct_id": "NCT00001091",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "4 Months",
      "maximum_age": "17 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "lamivudine",
      "nelfinavir mesylate",
      "nevirapine",
      "ritonavir",
      "stavudine"
    ],
    "outcomes": []
  },
  "title": "Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e1"
  },
  "nct_id": "NCT00001094",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Lamivudine / Zidovudine",
      "delavirdine mesylate",
      "nelfinavir mesylate",
      "saquinavir"
    ],
    "outcomes": []
  },
  "title": "A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e2"
  },
  "nct_id": "NCT00001092",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "The Biology of HIV Transmission"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e3"
  },
  "nct_id": "NCT00001093",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "Outcomes of Anti-HIV Therapy During Early HIV Infection"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e4"
  },
  "nct_id": "NCT00001095",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "amprenavir",
      "indinavir sulfate",
      "lamivudine",
      "nevirapine",
      "stavudine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e5"
  },
  "nct_id": "NCT00001096",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "HIV",
      "HIV-1",
      "MNSs Blood-Group System",
      "QS-21"
    ],
    "outcomes": []
  },
  "title": "A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e6"
  },
  "nct_id": "NCT00001097",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "8 Years",
      "maximum_age": "22 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e7"
  },
  "nct_id": "NCT00001100",
  "conditions": [
    "Cytomegalovirus Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "1 Month",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ganciclovir"
    ],
    "outcomes": []
  },
  "title": "A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections."
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e8"
  },
  "nct_id": "NCT00001101",
  "conditions": [
    "Lyme Disease"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ceftriaxone",
      "doxycycline"
    ],
    "outcomes": []
  },
  "title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51e9"
  },
  "nct_id": "NCT00001104",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ea"
  },
  "nct_id": "NCT00001102",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51eb"
  },
  "nct_id": "NCT00001103",
  "conditions": [
    "Cognition Disorders",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ec"
  },
  "nct_id": "NCT00001105",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Homo sapiens",
      "Monoclonal Antibodies"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ed"
  },
  "nct_id": "NCT00001106",
  "conditions": [
    "HIV Infections",
    "Pregnancy"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "1 Day",
      "maximum_age": "50 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ee"
  },
  "nct_id": "NCT00001107",
  "conditions": [
    "Candidiasis"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "AmBisome",
      "fluconazole"
    ],
    "outcomes": []
  },
  "title": "Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ef"
  },
  "nct_id": "NCT00001108",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "4 Years",
      "maximum_age": "22 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "lamivudine",
      "nelfinavir mesylate",
      "nevirapine",
      "ritonavir",
      "saquinavir",
      "stavudine"
    ],
    "outcomes": []
  },
  "title": "A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f0"
  },
  "nct_id": "NCT00001109",
  "conditions": [
    "HIV Infections",
    "HIV Seronegativity"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "1 Day",
      "maximum_age": "18 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "A Blood Test to Look at Cells of the Immune System in Healthy Children"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f1"
  },
  "nct_id": "NCT00001110",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Bronchoalveolar Lavage"
    ],
    "outcomes": []
  },
  "title": "Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f2"
  },
  "nct_id": "NCT00001112",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "65 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "interferon gamma-1b",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f3"
  },
  "nct_id": "NCT00001113",
  "conditions": [
    "HIV Infections",
    "Malignant neoplasm of soft tissue"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "IFNA2 protein, human",
      "interferon alfa-n1",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f4"
  },
  "nct_id": "NCT00001111",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "1 Day",
      "maximum_age": "17 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "nevirapine",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f5"
  },
  "nct_id": "NCT00001114",
  "conditions": [
    "HIV Infections",
    "Malignant neoplasm of soft tissue"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "IFNA2 gene",
      "didanosine"
    ],
    "outcomes": []
  },
  "title": "The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f6"
  },
  "nct_id": "NCT00001115",
  "conditions": [
    "HIV Infections",
    "Herpes Simplex Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "acyclovir"
    ],
    "outcomes": []
  },
  "title": "The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f7"
  },
  "nct_id": "NCT00001116",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Soluble (qualifier)",
      "tumor necrosis factor receptor superfamily complex"
    ],
    "outcomes": []
  },
  "title": "A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f8"
  },
  "nct_id": "NCT00001118",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "3 Years",
      "maximum_age": "12 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "enfuvirtide"
    ],
    "outcomes": []
  },
  "title": "Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51f9"
  },
  "nct_id": "NCT00001117",
  "conditions": [
    "HIV Infections",
    "Hepatitis C"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51fa"
  },
  "nct_id": "NCT00001120",
  "conditions": [
    "Acquired Immunodeficiency Syndrome",
    "Adult Lymphoma",
    "HIV Infections",
    "Lymphoma, Non-Hodgkin",
    "Malignant neoplasm of soft tissue",
    "Related personal status"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "A Study of Patients With AIDS Syndrome"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51fb"
  },
  "nct_id": "NCT00001119",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "16 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Hepatitis B Vaccines",
      "Lamivudine / Zidovudine",
      "Recombinants",
      "abacavir sulfate",
      "amprenavir",
      "efavirenz",
      "indinavir sulfate",
      "lamivudine",
      "ritonavir",
      "tetanus toxoid vaccine, inactivated",
      "zidovudine"
    ],
    "outcomes": []
  },
  "title": "Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51fc"
  },
  "nct_id": "NCT00001121",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "60 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51fd"
  },
  "nct_id": "NCT00001123",
  "conditions": [
    "Hantavirus Pulmonary Syndrome"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "12 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "ribavirin"
    ],
    "outcomes": []
  },
  "title": "A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51fe"
  },
  "nct_id": "NCT00001122",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "13 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "didanosine",
      "efavirenz",
      "nelfinavir mesylate",
      "stavudine"
    ],
    "outcomes": []
  },
  "title": "A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e51ff"
  },
  "nct_id": "NCT00001125",
  "conditions": [
    "Chickenpox",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "2 Years",
      "maximum_age": "18 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "% live",
      "Chickenpox Vaccine"
    ],
    "outcomes": []
  },
  "title": "Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e5200"
  },
  "nct_id": "NCT00001126",
  "conditions": [
    "Papilloma"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "2 Years",
      "maximum_age": "17 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "cidofovir"
    ],
    "outcomes": []
  },
  "title": "Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e5201"
  },
  "nct_id": "NCT00001127",
  "conditions": [
    "Influenza"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Months",
      "maximum_age": "18 Years",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "CA4 gene",
      "Influenza virus vaccine"
    ],
    "outcomes": []
  },
  "title": "Study of a Flu Vaccine in Children"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e5202"
  },
  "nct_id": "NCT00001090",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "400",
      "AIDSVAX",
      "CSF2 gene"
    ],
    "outcomes": []
  },
  "title": "A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e5203"
  },
  "nct_id": "NCT00001128",
  "conditions": [
    "Cryptosporidiosis",
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Recombinant Interleukin-12",
      "azithromycin",
      "paromomycin sulfate"
    ],
    "outcomes": []
  },
  "title": "Treatment of Chronic Cryptosporidiosis in AIDS Patients"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e5204"
  },
  "nct_id": "NCT00001130",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "18 Years",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [],
    "outcomes": []
  },
  "title": "Identifying Emergency Room Patients Who Have Recently Been Infected With HIV"
},
{
  "_id": {
    "$oid": "671a2b181845d98ae42e5205"
  },
  "nct_id": "NCT00001129",
  "conditions": [
    "HIV Infections"
  ],
  "pico_attributes": {
    "populations": {
      "minimum_age": "NA",
      "maximum_age": "NA",
      "country": "United States",
      "gender": "ALL"
    },
    "interventions": [
      "Authorization Mode - Electronic",
      "Medication Systems",
      "Medications",
      "Relationship - Manager",
      "Reminder",
      "Reminder Systems"
    ],
    "outcomes": []
  },
  "title": "A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly"
}]